NCT04200066 2022-08-22
A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
University of Rochester
Phase 1 Withdrawn
Clinical Trials
4 trialsNCT04038489 2021-11-22
Breast 51
University of Virginia
Phase 2 Withdrawn
NCT03238703 2018-12-27
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
Fred Hutchinson Cancer Center
Phase 4 Withdrawn
NCT00053339 2016-07-12
Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Withdrawn